ChristopherANovotnyMD

Cytopathology, Anatomic Pathology, Clinical Pathology

Physician

Are you Dr. Novotny?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Connect with colleagues in the same hospital or clinic
You already have 29 invites waiting!
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

Dr. Christopher Novotny, MD is a board certified pathologist in Charleston, South Carolina. He is currently licensed to practice medicine in South Carolina and Virginia. He is affiliated with Augusta Health, Salem Veterans Affairs Medical Center, and University of Virginia Medical Center.

University of Tennessee Medical Center at KnoxvilleResidency, Pathology-Anatomic and Clinical, 2003 - 2007
Eastern Virginia Medical SchoolInternship, Internal Medicine, 2002 - 2003
Wake Forest School of Medicine of Wake Forest Baptist Medical CenterClass of 2002

PubMed

1 citations
Dynamic Interactive Educational Diabetes Simulations Using the World Wide Web: An Experience of More Than 15 Years with AIDA Online
Eldon D. Lehmann, Dennis K. DeWolf, Christopher A. Novotny, Karen Reed, Robert R. Gotwals> ;International Journal of Endocrinology. 2014 Jan 6
Parallel synthesis and biological evaluation of 837 analogues of procaspase-activating compound 1 (PAC-1).
Hsu, D. C., Roth, H. S., West, D. C., Botham, R. C., Novotny, C. J., Schmid, S. C., Hergenrother, P. J.> ;ACS Comb Sci. 2012 Jan 9
Discovery and canine preclinical assessment of a nontoxic procaspase-3-activating compound.
Peterson, Q. P., Hsu, D. C., Novotny, C. J., West, D. C., Kim, D., Schmit, J. M., Dirikolu, L., Hergenrother, P. J., Fan, T. M.> ;Cancer Res. 2010 Sep 15
Pharmacokinetics and derivation of an anticancer dosing regimen for PAC-1, a preferential small molecule activator of procaspase-3, in healthy dogs.
Lucas, P. W., Schmit, J. M., Peterson, Q. P., West, D. C., Hsu, D. C., Novotny, C. J., Dirikolu, L., Churchwell, M. I., Doerge, D. R., Garrett, L. D., Hergenrother, P....> ;Invest New Drugs. 2011 Oct
Procaspase-3 activation as an anti-cancer strategy: structure-activity relationship of procaspase-activating compound 1 (PAC-1) and its cellular co-localization with c...
Peterson, Q. P., Hsu, D. C., Goode, D. R., Novotny, C. J., Totten, R. K., Hergenrother, P. J.> ;J Med Chem. 2009 Sep 24
Join now to see all